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Abstract Our previous study has demonstrated that hydrogen
sulfide (H2S) attenuates neuronal injury induced by vascular
dementia (VD) in rats, but the mechanism is still poorly un-
derstood. In this study, we aimed to investigate whether the
neuroprotection of H2S was associated with synaptic plasticity
and try to interpret the potential underlying mechanisms.
Adult male Wistar rats were suffered the ligation of bilateral
common carotid arteries. At 24 h after surgery, rats were ad-
ministered intraperitoneally with sodium hydrosulfide (NaHS,
5.6 mg·kg−1·day−1), a H2S donor, for 3 weeks in the VD+
NaHS group and treated intraperitoneally with saline in the
VD group respectively. Our results demonstrated that NaHS
significantly decreased the level of glutamate. It obviously
ameliorated cognitive flexibility as well as the spatial learning
and memory abilities byMorris water maze. Moreover, NaHS
significantly improved the long-term depression (LTD), and
was able to elevate the expression of N-methyl-D-aspartate
receptor subunit 2A, which plays a pivotal role in synaptic
plasticity. Interestingly, NaHS decreased the phosphorylation
of Akt, and it could maintain the activity of glycogen synthase
kinase-3β (GSK-3β). Surprisingly, NaHS triggered the ca-
nonical Notch pathway by increasing expressions of Jagged-
1 and Hes-1. These findings suggest that NaHS prevents syn-
aptic plasticity fromVD-induced damage partly via Akt/GSK-
3β pathway and Notch signaling pathway.
Keywords Hydrogensulfide .Vasculardementia .Long-term
depression . Hippocampus
Introduction
Epidemiological studies show that vascular dementia (VD) is
the second commonest cause of dementia after Alzheimer’s
disease (AD), and results from ischemic, ischemic-hypoxic, or
hemorrhagic brain lesions [1–4]. The feature of VD is histo-
pathological damage and progressive intellectual decline [5].
Unfortunately, the pathogenesis of the cognitive decline is still
not fully understood, and there are fewer drugs licensed for the
treatment of VD. The therapeutic strategy of VD is, so far,
limited to control of known vascular risk factors in clinic [6].
As we all know, both long-term potentiation (LTP) and
long-term depression (LTD) are two major forms of long-
lasting synaptic plasticity in mammalian brain, and both of
them are obviously characterized by a long-lasting increase
or decrease in synaptic strength, respectively. LTP and LTD
are considered to be related to the information storage, and
therefore to learning and memory and other physiological
processes. Glutamate, an important excitatory amino acid neu-
rotransmitter, plays a pivotal role in the central nervous system
[7, 8], and it acts on NMDARs (N-methyl-D-aspartate recep-
tors ), AMPARs (α-amino-3- hydroxy-5-methylisoxazole-4-
propionic acid receptors), KARs (kainate receptors), and
mGluRs (metabotropic glutamate receptors) during the pro-
cesses of LTP and LTD [9, 10]. However, high levels of glu-
tamate is neurotoxic [11]. Studies show that the concentration
of glutamate continues to be elevated in dementia and cerebral
Chunhua Liu and Xiaxia Xu contributed equally to this work.
* Zhuo Yang
zhuoyang@nankai.edu.cn
1 School of Medicine, State Key Laboratory of Medicinal Chemical
Biology, Tianjin Key Laboratory of Tumor Microenvironment and
Neurovascular Regulation, Nankai University, 94 Weijin Road,
Tianjin 300071, China
2 College of Life Sciences, Nankai University, 94 Weijin Road,
Tianjin 300071, China
Mol Neurobiol (2016) 53:4159–4172
DOI 10.1007/s12035-015-9324-x
ischemia [7, 12], which leads to the excessive flux of calcium
inside the neuron. Then, neuronal homeostasis is severely im-
paired and eventually, neurodegeneration happens [13]. Ac-
cumulating evidences indicate that the neurotoxic effects of
glutamate appear to be mediated mainly via activation of
NMDARs. Therefore, NMDARs appear to be a potential tar-
get for preventing progression of neurodegeneration. Theoret-
ically, if agents are able to block pathological stimulation of
NMDARs, they might be able to alleviate further neurodegen-
eration in VD [14]. And several promising results have been
recently reported for uncompetitive NMDAR antagonists in
the treatment of several forms of dementia [8, 14]. However,
discouraging findings have begun to accumulate, and almost
all of NMDAR antagonists of the clinical trials are terminated
because of either lack of efficacy or their side effects [15].
Given the complex pathogenesis of dementia, it is necessary
to develop more effective and safe agents.
Glycogen synthase kinase-3 (GSK-3) has recently
been discovered to be a key regulator of synaptic plas-
ticity [16]. GSK-3β activity is specifically involved in
LTD mediated by NMDAR (NMDAR-LTD) [16]. The
basal activity of GSK-3β is dependent on phosphoryla-
tion of Tyr216; on the contrary, the inhibition of GSK-
3β is dependent on the phosphorylation of Ser9 and
Ser389 [16, 17]. When GSK-3β activity is inhibited by
phosphorylation at Ser9 by Akt, the NMDAR-LTD will
be prevented [16]. In CNS, studies suggest that Notch
signaling regulates neuronal synaptic plasticity, and
therefore learning and memory [18]. There are Notch1,
2, 3, and 4 receptors of Notch signaling pathway [18].
Conditional deletion of Notch1 in postnatal hippocampus
disrupts both LTP and LTD, and leads to deficits in
learning and short-term memory [19]. When Notch sig-
naling is activated, it will release Notch intracellular do-
main (NICD) [20]. Interestingly, Notch signaling path-
way has crosstalk with other signaling pathways, such
as Akt, Wnt, and NF-κB pathways [18]. Studies report
that GSK-3β modulates Notch signaling via direct phos-
phorylation of NICD, and that the activity of GSK-3β
protects NICD from proteasome degradation [21].
Hydrogen sulfide (H2S), as a notorious toxic gas, is recog-
nized as the third gaseous signaling molecular along with
nitric oxide (NO) and carbonmonoxide (CO). It is synthesized
endogenously from cysteine or homocysteine by cystathio-
nine β-synthase (CBS) and cystathionine γ-lyase (CSE)
[22]. The production of H2S is high in the brain. Moreover,
H2S has been considered as a neuromodulator. A previous
study demonstrate that H2S facilitates the induction of hippo-
campal LTP by enhancing the activity of NMDARs in neurons
[23]. Our previous study has demonstrated that H2S improves
LTP in hippocampus and inhibits the neuronal death induced
by bilateral common carotid arteries ligation [24]. In addition,
Zhang et al. have showed that H2S attenuates neuronal injury
induced by VD via inhibiting apoptosis [25]. However, the
mechanism of H2S on VD is poorly understood. In this study,
we ligated bilateral common carotid artery to induce the rat
model of VD, then evaluated the cognitive function byMorris
water maze and LTD, and aimed to investigate whether the
GSK-3β and Notch signaling pathway played an important
role on H2S against VD.
Materials and Methods
Animal Care
Adult male 250–300 g Wistar rats were purchased from the
Laboratory Animal Center, Academy ofMilitary Medical Sci-
ence of People’s Liberation Army. Rats were reared at specific
pathogen-free condition under a 12-h light-dark cycle with
lights on from 8 a.m. Food and water were freely available.
All animal experiments were approved by the Animal Re-
search Ethics Committee, School of Medicine, Nankai Uni-
versity. In addition, all animal experiments were performed in
accordance with the Animal Management Rules of the Min-
istry of Health of the People’s Republic of China.
Induction of VD
Rats were randomly assigned into three groups, i.e.,
sham group (n=6), VD group (n=8), and VD + sodium
hydrosulfide (VD+NaHS) group (n=8). The rat model of
VD was established as previously described [24]. Briefly,
rats were anesthetized by injecting 10 % chloral hydrate
(35 mg·kg−1, i.p.), and were subjected to hair shaving
before the surgical operation. Secondly, a longitudinal
midline incision was made in the neck to expose the left
and right common carotid artery. Finally, bilateral com-
mon carotid arteries were ligated with a 4–0 polypropyl-
ene in the VD and VD+NaHS groups. For the sham
group, all operative procedures were performed identical-
ly, except for common carotid artery ligation. Rectal tem-
perature was continually monitored and maintained at
36.5–37.5 °C with a heating blanket during VD surgery.
Following surgery, rats were placed on a heating blanket
until they recovered from the anesthesia, then they were
placed in their cages and freely accessed food and water.
At 24 h after surgery, the survival rate of the sham group
was 100 %, and the survival rates of the VD and VD+
NaHS groups were 75 %. Then, rats were injected intra-
peritoneally with NaHS (n=6, 5.6 mg·kg−1·day−1, i.p.)
daily for 3 weeks in the VD+NaHS group. And rats in
the VD group were injected intraperitoneally with saline
(n=6, saline, i.p.).
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Morris Water Maze (MWM) Experiment
After 3 weeks post-injury, the spatial learning and memory
ability of rats was measured by MWM as previously reported
[26, 27]. The tank for MWM test was 150 cm in diameter and
60 cm in height and was filled with water to the depth of
45 cm. Nontoxic black ink was poured into water to make it
dark. The tank was divided into four quadrants, namely zones
1, 2, 3 and 4. The MWM experiment comprised of four
phases, i.e., initial training (IT), initial probe trials (IPT), re-
versal training (RT), and reversal probe trials (RPT). In IT
stage, the 10-cm-diameter platformwas submerged in the cen-
ter of zone 1. Rats were trained every day with two sessions
for 8-h interval. Each session consisted of four trials and each
trial was performed for 60 s. Rats were placed into water at
different quadrants in each session, respectively. They were
allowed to swim freely until they stayed on the platform for at
least 5 s. If failed to find the platform within 60 s, rats would
be guided to the platform and stayed on it for 15 s. Both of the
escape latency (time required to find the platform) and the
swimming speed were recorded. On the fifth day, the IPT
stage was performed. In this stage, the platform was removed.
Rats were put into water and allowed to swim for 60 s, respec-
tively. In this process, the platform crossings and quadrant
dwell time were recorded. In RT stage, rats were trained every
day with two sessions for 8-h interval. The platform was
placed in the center of zone 4. Methods and parameters re-
corded were the same as those in IT stage. Both of the escape
latency and the swimming speed were recorded. In RPTstage,
the method was the same as that in IPT stage. Both of the
quadrant dwell time and platform crossings were recorded.
Long-Term Depression Recording
The long-term depression (LTD) recording was performed on
rats after MWM experiment. LTD recording was performed as
previously described [27, 28]. Rats were anesthetized by 30%
urethane anesthesia with a dosage of 4 ml/kg by intraperito-
neal injection (Sigma-Aldrich, St. Louis, MO, USA) and po-
sitioned on a stereotaxic frame (SR-6N; Narishige, Japan).
Recordings of the field excitatory post-synaptic potentials
(fEPSPs) were made from the CA3 region (4.2 mm posterior
to the bregma, 3.5 mm lateral to midline, 2.5 mm ventral
below the dura) to the CA1 region (3.5 mm posterior to the
bregma, 2.5 mm lateral to midline, 2.0 mm ventral below the
dura). When the stable curves were obtained, baseline re-
sponses were recorded for 20 min. Then low-frequency stim-
ulation (LFS) (900 pulses of 1 Hz for 15 min) was delivered to
induce LTD. Following LFS, the amplitude of fEPSPs would
be resumed for a further period of 60 min. After LTD record-
ing, all rats were sacrificed. The hippocampus of the left brain
was quickly removed at 4 °C and stocked at −70 °C. The right
brain was quickly removed at 4 °C and immersed in 4 %
paraformaldehyde fixed at 4 °C for 24 h, and then, they were
dehydrated in sucrose solution and embedded with embed-
ding medium of OCT at −20 °C for tissue section. The coro-
nary slices (5 μm) were obtained and used for immunofluo-
rescence staining of NMDAR2A (NR2A) and NMDAR2B
(NR2B).
Measurement of H2S
The concentration of H2S in hippocampus was determined as
described previously [24]. Briefly, the hippocampus was ho-
mogenized in 50 mmol·L−1 potassium phosphate buffer at
4 °C, pH 8.0 (12 % w·v−1). The homogenate was centrifuged
at 12,000 rpm for 10min at 4 °C, and then 75μl of supernatant
was added to a 1.5-ml microtube containing 0.25 ml of 1 %
zinc acetate. Thirdly, both of 20 mM of N, N-dimethyl-p-
phenylendiammonium (NNDPD) in 7.2 M HCl and 30 mM
FeCl3 in 1.2 M HCl were put into the microtube. The solution
was then incubated at room temperature for 10 min. Next,
0.25 ml of 10 % TCAwas added in order to remove proteins.
Finally, the solution was centrifuged at 12,000 rpm for 10 min
at 4 °C. The optical absorbance of the resulting solution was
measured at 670 nm using a 96-well microplate reader. Each
sample was measured in duplicate and the concentration of
H2S was calculated against a standard calibration curve of
NaHS (3.125–250 μM), which was performed on the same
condition as the sample.
Measurement of Glutamate
The levels of glutamate of hippocampus in all three groups
were measured using the kit (Jiancheng, Nanjing, China) ac-
cording to the manufacturer’s protocol.
Western Blot Assay
The Western blot assay was performed as previously de-
scribed [29]. Briefly, the rat hippocampus was homogenized
in lysis buffer (Beyotime Biotechnology, Haimen, China) and
centrifuged at 12,000 rpm for 10 min at 4 °C. The concentra-
tion of hippocampal protein was measured by using enhanced
BCA protein assay kit (Beyotime Biotechnology, Haimen,
China). The hippocampal protein lysates were separated on
either 10 or 12 % SDS-PAGE gels, and then 50-μg proteins
were transferred onto 0.22-μm polyvinylidene difluoride
(PVDF) membrane (Promega Co. Ltd.) at 4 °C. Thirdly, the
membrane was blocked in Tris-buffered saline with Tween-20
(TBST) containing 5 % skim milk for 1.5 h at room temper-
ature. Fourthly, the PVDF membrane was incubated with pri-
mary antibody NR2A; NR2B; Hes-1; Jagged-1 (1:2000,
Abcam, UK); GSK-3α/β; p-GSK-3βser9; Akt; p-Aktser437
(1:2000, Cell Signaling Technology, USA); CBS (Santa Cruz
Biotechnology, USA); and β-actin (1:4000, Abcam, UK).
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Antibodies were diluted in TBST containing 5 % skim milk
overnight at 4 °C. Finally, the second antibody (1:8000,
Abcam, UK) was diluted in TBST. Protein band intensities
were analyzed by using a Western blot detection system.
Immunofluorescence Staining
According to the method described by Liu et al. [30], the
immunofluorescence study was carried out as follows. Brain
sections were washed in PBS for three times; subsequently,
they were blocked with 10 % goat serum for 1 h at room
temperature. Thirdly, brain sections were incubated with
NR2A and NR2B (1:1000, Abcam, UK) for 18 h at 4 °C.
Fourthly, they were washed by PBS for three times and incu-
bated with Alexa 488-conjugated anti-rabbit IgG for 6 h at
room temperature. Finally, they were stained with 4 ,6-
diamidino-2-phenylindole (DAPI) for 3 min at room temper-
ature and the fluorescent signals were detected by laser scan-
ning confocal microscope.
Statistical Analysis
Data were analyzed by SPSS 16.0 software. The results of
escape latencies and swimming speeds in MWM test were
analyzed by two-way repeated measures ANOVA followed
by the Bonferroni multiple group comparison. The results of
the platform crossings, quadrant dwell time, the temporal dis-
tribution of the quadrants, LTD recording, content of H2S and
glutamate, and expression of proteins between three groups
were performed using one-way ANOVA followed by a post
hoc Turkey test. Data were presented as means±S.E.M. and
defined differences at p<0.05 as statistically significant. All
pictures were processed with Photoshop software.
Results
NaHS Decreased the Concentration of Glutamate,
Elevated the Level of H2S, and the Expression of CBS
in Hippocampus
Levels of H2S and glutamate in hippocampus were measured.
Our data showed that the level of glutamate was obviously
increased in hippocampus of the VD group compared with that
of the sham group (p<0.01, Fig. 1a). And the concentration of
H2S was obviously decreased in the VD group. When admin-
istrated with NaHS, the concentration of glutamate in hippo-
campus was alleviated from 120.31±6.11 to 109.24±
6.16 μmol·g−1 protein. Moreover, the content of H2S was sig-
nificantly improved from 18.25±2.72 to 28.75±2.06 μmol·g−1
protein (p<0.05, Fig. 1a, b). As shown in Fig. 1c, the expres-
sion of CBSwasmarkedly decreased in the VD group, whereas
NaHS remarkably improved the level of CBS (p<0.01).
NaHS Ameliorated the Impaired Spatial Learning
and Memory Abilities
In order to detect the effect of NaHS on spatial cognition, spatial
learning and memory abilities were examined by MWM. Our
data showed that the average escape latency was markedly
Fig. 1 The contents of glutamate and H2S and the expression of CBS in
hippocampus of the sham, VD, and VD+NaHS groups. a The content of
glutamate. b The content of H2S. c Quantitative analysis of protein
expression of CBS. Data are expressed as mean±S.E.M. ##p<0.01
comparison between sham group vs. VD group. *p<0.05, comparison
between VD+NaHS vs. VD groups. n=4 per group
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decreased in all three groups during the IT stage without affect-
ing swimming speeds (Fig. 2a, b), but rats in the VD group
spent more time to find the platform compared with those in
the sham group (p<0.05, Fig. 2a). Interestingly, when admin-
istrated with NaHS, it was able to succeed in locating the plat-
form much more quickly (p<0.05, Fig. 2a). In the IPT stage,
our results indicated that both the platform crossings and the
quadrant dwell time were obviously decreased in the VD group
(1.60±0.21 and 28.39±3.33 %, respectively, p<0.01) (Fig. 2c,
d), whereas NaHS remarkably improved both the platform
crossings and the quadrant dwell time to 2.33±0.30 and
36.11±2.94 %, respectively (p<0.05, Fig. 2c, d).
Fig. 2 Measurement of spatial learning and reversal learning. a Escape
latency calculated for each day in the sham, VD, and VD+NaHS groups
on each training day in the IT and RT stages. b Swimming speed on each
training day in the IT and RT stages. c Platform area crossings in the IPT
stage within 1 min. d Percentage of time in the target quadrant in the IPT
stage within 1 min. e Platform area crossings in RPTstage within 1 min. f
Percentage of time in target quadrant in RPT stage within 1 min. Data are
expressed as mean ± S.E.M. #p<0.05, ##p<0.01 comparison between the
sham vs. VD groups. *p<0.05, **p<0.01 comparison between the VD+
NaHS vs. VD groups. n=6 per group
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The ability of reversal learning was performed to
examine the effects of NaHS. During RT stage, the time
of locating the hidden platform was markedly longer in
the VD group than that of the sham group on days 6
and 7 (p<0.05, Fig. 2a). Although NaHS failed to
shorten the time of seeking the platform on the sixth
day, it was able to reduce the average escape latency
on the seventh day without affecting swimming speeds
(p<0.05, Fig. 2a, b). Other than that, it was found that
both the platform crossings and the quadrant dwell time
in RPT stage were obviously increased in the VD+
NaHS group compared with those in the VD group
(p<0.05, Fig. 2e, f). In addition, the temporal distribu-
tion of the quadrants was analyzed in this study. When
the hidden platform was located in zone 4 in the RT
stage, rats of the VD group spent more time to seek the
platform in zone 1 (original quadrant) compared with
the sham group (p<0.01, Fig. 3a) on the seventh day.
In contrast, rats in the VD group spent less time in zone
4 (novel quadrant) compared with that of the sham
group (p<0.05, Fig. 3d). There was no significant dif-
ference in the time spent in zones 2 and 3 between the
VD and the VD+NaHS groups (p>0.05), but NaHS was
able to decrease the time spending in zone 1 and im-
prove the time spending in zone 4 on the seventh day
(p<0.05, Fig. 3a–d). The swim traces of all the three
groups in the RT stage were showed in Fig. 3e. It can
be seen that there was a short trajectory of reversal
learning stage in both the sham and the VD+NaHS
group, whereas the trajectory of the VD group was ob-
viously longer (Fig. 3e). In addition, it was found that
there were obviously more swimming trajectories in the
original quadrant (zone 1) in the VD group compared to
those in the VD+NaHS group. However, rats of the
VD+NaHS group spent more time in the novel quadrant
(zone 4) rather than other zones compared with the VD
group.
NaHS Ameliorated the Impaired Long-Term Depression
in Hippocampus
The LTD recording was performed to investigate the effects of
NaHS on synaptic plasticity induced by VD. As shown in
Fig. 4a, fEPSPs slopes were significantly decreased after the
low-frequency stimulation from CA3 to CA1 regions and
remained lower than the baseline in the sham group. And
the fEPSPs slope was higher in the VD group, which indicated
that LTD was suppressed in VD group compared with that of
the sham group (p<0.01, Fig. 4a, b). However, NaHS was
able to reduce the fEPSPs slopes and maintained lower, which
indicated that NaHS ameliorated the impaired synaptic plas-
ticity induced by VD (p<0.01, Fig. 4a, b).
NaHS Modulated Cognitive Function-Associated Protein
Expressions
The cognitive function-related proteins were examined
by Western blot assay and immunofluorescence staining.
Although there was no change of NR2B expression in
hippocampus of the VD group (p>0.05, Fig. 5a, c),
NR2A expression was obviously downregulated to
0.50-fold compared with that of the sham group, then
the ratio of NR2A/2B was decreased to 0.53 (p<0.01,
Fig. 5). Interestingly, NaHS was able to increase the
level of NR2A to 0.84-fold and downregulated the ex-
pression of NR2B to 0.81-fold so as to improve the
ratio of NR2A/2B to 0.91 (p<0.01, Fig. 5). As shown
in Fig. 6, both NR2A and NR2B were stained with
green fluorescence by Alexa 488-conjugated anti-rabbit
IgG. Nuclei in hippocampus were stained with blue
fluorescence by DAPI. The protein expression of
NR2A was presented by either green point shape distri-
bution or a green ring around nucleus in the left and
right columns in Fig. 6a. In the VD group, the expres-
sion of NR2A was obviously decreased compared with
that of the sham group, which was consistent with the
result of Western blot in Fig. 5. When treated with
NaHS, it was markedly increased in expression of
NR2A (Fig. 6a). On the other hand, there was no dif-
ference in the expression of NR2B between the three
groups (Fig. 6b), which was consistent with the result
of Western blot in Fig. 5.
The Neuroprotective Mechanism of NaHS on VD
To investigate the signal transduction pathway of NaHS
on VD, neuroprotective mechanism-related proteins were
examined using Western blot assay. There was no sig-
nificant difference in Akt expression between the three
groups, but phosphorylated Akt (p-Akt) was markedly
increased in the VD group (p<0.05, Fig. 7a, b). Al-
though NaHS failed to modulate the expression of Akt
in hippocampus, it was able to reduce the p-Akt expres-
sion so as to decrease the ratio of p-Akt/Akt to 0.85 (p
<0.05;, Fig. 7a–b, e). There was no difference in the ex-
pression of phosphorylated GSK-3β (p-GSK-3β) and GSK-
3α between the VD and sham groups, but the expression of
GSK-3β was obviously downregulated to 0.84 in the VD
group, which increased the ratio of p-GSK-3β/GSK-3β to
1.18 (p<0.05, Fig. 7c–d, f). However, NaHS was able to up-
regulate the expression of GSK-3β to 1.04, which was bene-
ficial to reduce the ratio of p-GSK-3β/GSK-3β to 0.97
(p<0.05, Fig. 7c, f). As shown in Fig. 8a–b, the expression
of Hes-1 and Jagged-1 was significantly reduced in VD group
(p<0.01). Interestingly, NaHS was markedly alleviated levels
of Hes-1 and Jagged-1 to 1.55- and 0.74-fold, respectively
4164 Mol Neurobiol (2016) 53:4159–4172
(p<0.01). The linear relationship between the GSK-3β and
the expression levels of Jagged-1 and Hes-1 proteins were also
analyzed. In our study, the protein expression of Jagged-1 was
not correlated with GSK-3β (r=0.271, p=0.276; Fig. 8c).
However, the expression of Hes-1 was positively correlated
with GSK-3β (r=0.571, p=0.013; Fig. 8d).
Discussion
Accumulating evidences indicate that VD is the second
commonest cause of dementia after Alzheimer’s disease
(AD) [1]. However, the pathogenesis of VD is so far
largely unknown and is likely multifactorial [1]. In our
Fig. 3 Comparison of temporal distribution in each quadrant of RTstage.
a The temporal distribution in zone 1. b The temporal distribution in zone
2. c The temporal distribution in zone 3. d The temporal distribution in
zone 4. Data are expressed as mean±S.E.M. ##p<0.01 comparison
between the sham vs. VD groups. e Representative swim traces of rats
for each day in the sham, VD, and VD+NaHS groups. *p<0.05
comparison between the VD+NaHS vs. VD group. n=6 per group
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previous study, we reported that NaHS played a neuro-
protective role on VD rats, but the underlying mecha-
nism remained, so far, poorly understood.
Glutamate is an important excitatory amino acid neuro-
transmitter and plays a key role in the central nervous system
[13]. However, high levels of glutamate show excitotoxicity,
which is a critical mechanism contributing to neuronal death
[31]. Several studies showed that the concentration of gluta-
mate continued to be elevated in ischemia and dementia
[12, 32, 33]. The high level of glutamate in hippocampus of
VD rats was observed in our experiment, which indicated that
VD was able to disturb the glutamate level of rats and led to
Fig. 4 The effects of NaHS on LTD from CA3 to CA1 region of
hippocampus. a Alterations in fEPSPs slopes after LFS in the sham,
VD, and VD+NaHS groups. b Changes in fEPSPs slope in the sham,
VD, and VD+NaHS groups. Data are expressed as mean±S.E.M.
##p<0.01 comparison between the sham vs. VD groups. **p<0.01
comparison between the VD+NaHS vs. VD groups. n=6 for group
Fig. 5 The expression of cognitive function associated protein detected
by Western blot assay in hippocampus of the sham, VD, and VD+NaHS
groups. a Quantitative analysis of protein expression of NR2A. b
Quantitative analysis of protein expression of NR2B. c The ratio of
NR2A/NR2B. Data are expressed as mean±S.E.M. ##p<0.01
comparison between the sham vs. VD groups. **p<0.01 comparison
between the VD+NaHS vs. VD groups. n=4 per group
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excitotoxicity. When administrated with NaHS, the level of
glutamate was significantly decreased. Although the gluta-
mate level was decreased in hippocampus of VD rats by
NaHS, it’s still hard to directly say that the neurotransmitter
glutamate was changed according to our present data, which
only suggested indirectly that the impairment of glutamate
system could be alleviated by NaHS to some extent. There-
fore, the underlyingmechanism of NaHS on glutamate system
still need to be further studied.
As known, H2S is mainly produced from L-cysteine (Cys)
and homocysteine (Hcy) by CBS in the brain [34]. It was
found that the plasma Hcy level of VD was significantly
higher than that of normal control in clinical research, which
suggested that the ability to transfer Hcy to H2S by CBS was
damaged [35]. Zhang et al. have reported that the neuronal
injury occurs with a decreasing number of neurons and an
increasing apoptosis ratio in hippocampus after VD, while
the H2S level is also decreased in plasma after VD [25]. Our
previous study have reported that there is a clear edema and
nuclear shrink phenomenon around pyramidal neurons in VD
rats accompanied with decrease of H2S in VD rats, which is
consistent with Zhang’s results [24, 25]. In this experiment,
the level of H2S and expression of CBS were decreased in the
VD group, which could be related to the apoptosis of neurons.
When the death of neuron occurred, the capability to synthe-
size the protein of CBS could be damaged in neuron and
therefore led to the decrease of the ability to generate H2S.
Interestingly, NaHS could significantly attenuate neuronal
death after VD [25]. Furthermore, studies have reported that
the activation of NR2A is also beneficial to neuronal survival
[36]. Our data showed that the expression of NR2A in VD+
NaHS group was obviously upregulated compared with that
of the VD group, and helped rats survive from neuronal death
induced by VD. Thereafter, the synthesis and activity of CBS
could be maintained in neurons, which could contribute to
improving the production of H2S to some extent.
In our study, the MWM task was performed to evaluate the
neuroprotection of NaHS. In the IT stage, NaHS was able to
effectively alleviate cognitive deficiency to some extent,
which was consistent with Li’s results [16]. Then, spatial re-
versal learningwas carried out. On the second day of RTstage,
rats in the VD group spent more time in zone 4 compared with
other zones, but they obstinately searched the platform in zone
1 (the original quadrant). These results suggested that infor-
mation storage was severely disrupted by VD. In contrast, rats
in the VD+NaHS group could locate the platformmuch easier
than that of the VD group, and they spent more time in zone 4
and less time in zone 1 than that of the VD group. It suggested
that they developed a new strategy and explored the platform
in the novel environment. Our results indicated that NaHS not
only contributed to improve the spatial memory, but also ame-
liorate the deficits in cognitive flexibility.
As known, the LTD in hippocampus plays an important
role in cognitive flexibility [28]. Actually, LTD could contrib-
ute to weaken previous memory traces; thus, in demand of a
task change, it may prevent those traces from interfering with
Fig. 6 The expression of NR2A and NR2B detected by
immunofluorescence staining (×400) in the CA1 region of
hippocampus in the sham, VD, and VD+NaHS groups. Both of NR2A
and NR2B were stained with green fluorescence by Alexa 488-
conjugated anti-rabbit IgG. Nuclei of hippocampus were stained with
blue fluorescence by DAPI. The protein expression of NR2A and
NR2B were presented in the left columns, the morphology of nucleus
was presented in the middle columns, and the merge pictures were pre-
sented in the right columns. Both NR2A and NR2B were presented by
either green point shape distribution or a green ring around the nucleus in
the left and right columns. Red arrow denotes NR2A expression in
Fig. 6a and yellow arrow denotes NR2B expression Fig. 6b. Scale
bar=30 μm
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Fig. 7 The expression of Akt, p-Akt, and GSK-3 detected by Western
blot assay in hippocampus of sham, VD, and VD+NaHS groups. aQuan-
titative analysis of protein expression of Akt. b Quantitative analysis of
protein expression of p-Akt. c Quantitative analysis of protein expression
of GSK-3α/β. d Quantitative analysis of protein expression of p-GSK-
3β. e Quantitative analysis of the ratio of p-Akt/Akt. f Quantitative anal-
ysis of the ratio of p-GSK-3β/GSK-3β. Data are expressed as mean±
S.E.M. #p<0.05, ##p<0.01 comparison between the sham vs.VD groups.
*p<0.05, **p<0.01 comparison between the VD+NaHS vs. VD groups.
n=4 per group
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newly encoded information [28]. In this study, the capacity of
behavioral flexibility partly weakened in the VD group. How-
ever, NaHS alleviated that deficiency to some extent. Subse-
quently, the LTD of hippocampus was recorded. Our results
showed that VD induced the increase of fEPSP slope, which
demonstrated that the synaptic plasticity was damaged. How-
ever, the impaired LTD was alleviated by the treatment of
NaHS, which was consistent with the result of spatial reversal
learning. Our data suggested that NaHS was able to prevent
rats from the impairment of synaptic plasticity induced by
VD.
Then, how does NaHS affect the synaptic plasticity? We
inferred that NMDARs may be involved. Functional
NMDARs are hetero-oligomeric proteins, which were com-
posed of NR1 subunit and NR2 or NR3 subunits [37–39].
NR2A and NR2B were prevailing in adult cortex and hippo-
campus. Liu et al. showed that selectively blocking NR2B
abolished the induction of LTD but not LTP. On the other
hand, preferential inhibition of NR2A prevented the induction
of LTP without affecting LTD production. By contrast, other
studies found that inhibition of NR2A impaired LTP and also
blocked LTD [24]. Thus, studies into the NMDAR subunit
dependence of LTD produced even more contradictory re-
sults, making it hard to draw unifying conclusions [40]. In
addition, NR2A is predominantly confined to synapses of
mature neurons, while NR2B is distributed mainly
extrasynaptically [37]. Studies both in vivo and in vitro report-
ed that activation of either synaptic or extrasynaptic NR2B
resulted in excitotoxicity and increasing neuronal apoptosis
[36, 37]. However, the activation of either synaptic or
extrasynaptic NR2A promoted neuronal survival and present-
ed a neuroprotective action against both NMDA receptor-
mediated and non-NMDA receptor-mediated neuronal dam-
age [36]. Our data showed that the expression of NR2Awas
Fig. 8 The expression of Jagged-1 and Hes-1 detected by Western blot
assay in hippocampus of the sham, VD, and VD+NaHS groups. a Quan-
titative analysis of protein expression of Jagged-1. bQuantitative analysis
of protein expression of Hes-1. c The correlation of Jagged-1 and GSK-
3β. d The correlation of Hes-1 and GSK-3β. Data are expressed as mean
±S.E.M. ##p<0.01 comparison between the sham vs.VD groups.
**p<0.01 comparison between VD+NaHS vs. VD group. n=4 per group
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obviously decreased in hippocampus of VD rats, which sug-
gested that the synaptic plasticity and capability of neuronal
survival was markedly weakened in VD group. Surprisingly,
the expression of NR2A was dramatically upregulated in the
VD+NaHS group, which was beneficial to help rats prevent
plasticity and survive from damage induced by VD. Accord-
ing to our results, we considered that NR2A subunits domi-
nated over NR2B subunits with respect to both plasticity and
neuronal survival on VD.
There are two isoforms of glycogen synthase kinase-3
(GSK-3), viz GSK-3α and GSK-3β, which is comprehensive-
ly expressed and involved in a variety of biological processes
[41]. The high enzymatic activity is inhibited upon phosphor-
ylation on residue ser9 of GSK-3β byAkt [42].With regard to
synaptic plasticity, GSK-3 appears to be essential for LTD,
and the inhibition of GSK-3 prevents the induction of LTD
[43]. In this experiment, VD induced a dramatic increase in
the phosphorylation of Akt (p-Akt), which was consistent
with Shu et al.’s results [44], and decreased the activity of
GSK-3β. Fortunately, the expression of p-Akt was markedly
reduced and maintained the activity of GSK-3β by NaHS.
Therefore we inferred that NaHS modulated LTD partly via
Akt/GSK-3β pathway.
In CNS, studies suggest that Notch signaling regulates neu-
ronal plasticity, learning, and memory [18]. There are four
Notch receptors, viz Notch1, 2, 3, and 4, and they are activated
by specific ligands of the Jagged and Delta serrate member
families. When ligands bind to Notch receptors, the proteolyt-
ic cleavage of Notch occurs. Subsequently, Notch receptors
release the Notch intracellular domain (NICD). NICD is, then,
translocated to nucleus to form a complex with the transcrip-
tion factor CBF1/RBP-Jκ, which bind to their target genes
such as Hes-1 and Hes-5 [20]. Interestingly, it appears that
the reduction of Notch signaling affects sensory and memory
processing [18]. Alberi et al. reported that conditional deletion
of Notch1 in the postnatal hippocampus disrupted both LTP
and LTD, and led to deficits in learning and short-term mem-
ory [19]. Our data showed that NaHS was able to ameliorate
the decrease expression of Jagged-1. Moreover, the expres-
sion of Hes-1 was dramatically increased in the VD+NaHS
group, suggesting a potential role of Notch on the neuropro-
tective effect of NaHS in VD rats’ brain. Our results implicat-
ed that NaHS modulated Notch signaling pathway by increas-
ing not only its ligands but also its downstream target genes.
Although NaHS upregulated the expression of Jagged-1, it
was still lower than that of the sham group. In contrast, the
expression of Hes-1 was dramatically elevated, of which level
was much higher than that of the sham group. Considering
these results obtained, we speculated that NaHS enhanced the
expression of Hes-1, possibly not only by upregulating li-
gands of Notch receptors. As known, Notch receptors modu-
late transcriptional targets following the proteolytic release of
NICD, of which will be phosphorylated before translocating
into the nucleus. Moreover, the phosphorylation of NICD has
been identified within the nucleus and is imperative for
translocating into the nucleus [45]. Studies report that GSK-
3β modulates Notch signaling via direct phosphorylation of
NICD, and that the activity of GSK-3β protects NICD from
proteasome degradation [21]. In our present experiment, our
data showed that NaHS not only improved the expression of
GSK-3β, but also downregulated the phosphorylation of Akt
in order to maintain the activity of GSK-3β. In addition, the
expression of Hes-1 was positively correlated with GSK-3β,
which suggested that GSK-3β could play an important role on
the expression of Hes-1. In view of these results above, we
speculated that NaHS protected NICD from proteasome deg-
radation partly via Akt/GSK-3β pathway in order to elevate
the expression of Hes-1.
In summary, we reported the neuroprotective effect of
NaHS on VD rats. And our study demonstrated that
NaHS was able to alleviate the excitotoxicity induced
by VD through decreasing the level of glutamate, and
elevate the expression of CBS to maintain the physical
level of H2S. Moreover, NaHS reduced LTD to improve
the performance of VD rats, which was confirmed by
the spatial learning and memory abilities by MWM.
Interestingly, NaHS reduced the phosphorylation of
Akt and maintained the activity of GSK-3β, which
was essential for LTD. Surprisingly, the canonical Notch
signal pathway was triggered to ameliorate the impaired
cognitive function in the VD+NaHS group. Thus, we
conclude that NaHS prevents synaptic plasticity from
VD-induced damage partly via Akt/GSK-3β pathway
and Notch signaling pathway. Our investigation will
shed new light on the mechanism of the neuroprotection
of H2S on VD and might be used as a therapeutic
method to cure neurodegenerative diseases.
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